Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.

[1]  James Robert Brašić,et al.  Children’s Global Assessment Scale , 2015 .

[2]  M. DelBello,et al.  Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder. , 2013, Journal of child and adolescent psychopharmacology.

[3]  K. Wagner,et al.  Bipolar disorder in adolescence. , 2013, Adolescent medicine: state of the art reviews.

[4]  P. Sienaert,et al.  Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. , 2013, The American journal of psychiatry.

[5]  M. DelBello,et al.  Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial. , 2013, The Journal of clinical psychiatry.

[6]  M. Olfson,et al.  National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. , 2012, Archives of general psychiatry.

[7]  N. Ryan,et al.  Predictors of prospectively examined suicide attempts among youth with bipolar disorder. , 2012, Archives of general psychiatry.

[8]  N. Ryan,et al.  Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. , 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  P. Lavori,et al.  A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. , 2012, Archives of general psychiatry.

[10]  T. Suppes,et al.  Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. , 2010, The Journal of clinical psychiatry.

[11]  M. DelBello,et al.  Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. , 2010, Bipolar disorders.

[12]  M. DelBello,et al.  Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. , 2009, Bipolar disorders.

[13]  K. Chang,et al.  Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. , 2009, The Journal of clinical psychiatry.

[14]  K. Chang,et al.  A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[15]  Rebecca Tillman,et al.  Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. , 2008, Archives of general psychiatry.

[16]  M. Monuteaux,et al.  Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study. , 2008, Drug and alcohol dependence.

[17]  M. Tohen,et al.  Olanzapine versus placebo in the treatment of adolescents with bipolar mania. , 2007, The American journal of psychiatry.

[18]  T. Wilens,et al.  A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. , 2006, The American journal of psychiatry.

[19]  P. Janicak,et al.  A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. , 2006, Journal of child and adolescent psychopharmacology.

[20]  M. DelBello,et al.  A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  H. Pincus,et al.  Concomitant pharmacotherapy among youths treated in routine psychiatric practice. , 2005, Journal of child and adolescent psychopharmacology.

[22]  P. Lavori,et al.  Placebo‐free designs for evaluating new mental health treatments: the use of adaptive treatment strategies , 2004, Statistics in medicine.

[23]  P. Janicak,et al.  Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. , 2004, Journal of affective disorders.

[24]  Rebecca Tillman,et al.  Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. , 2004, Archives of general psychiatry.

[25]  S. Strakowski,et al.  A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  M Williams,et al.  Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[27]  Robert M. Post,et al.  Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP , 1997, Psychiatry Research.

[28]  William J. Marks,et al.  Deep Brain Stimulation Management: Abnormal Involuntary Movement Scale , 2010 .

[29]  N. Ryan,et al.  A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents. , 2003, Journal of child and adolescent psychopharmacology.

[30]  A. Robb.  Bipolar disorder in children and adolescents. , 1999, Current opinion in pediatrics.

[31]  M. Gould,et al.  Aggregating data from multiple informants in child psychiatry epidemiological research. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.